RCUS · Arcus Biosciences, Inc.
Market Cap
$3.75B
Shares
127.33M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-06-12 | 2026-06-11 | |
| Investor Event Transcript | 2026-06-09 | 2026-06-30 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-21 | 2026-06-11 | |
| 8-K | 2026-04-20 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-23 | 2026-03-17 | |
| 8-K | 2026-02-25 | — | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2025-12-18 | — | |
| 8-K | 2025-12-12 | — | |
| 8-K | 2025-11-03 | 2025-10-30 | |
| 8-K | 2025-10-28 | — | |
| 10-Q | 2025-10-28 | 2025-09-30 | |
| 8-K | 2025-10-14 | 2025-10-12 | |
| 8-K | 2025-10-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-12 | 2025-06-10 | |
| 8-K | 2025-06-02 | 2025-06-01 | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-22 | 2025-06-10 | |
| 10-K | 2025-02-25 | 2024-12-31 | |
| 8-K | 2025-02-25 | — | |
| 8-K | 2025-02-19 | 2025-02-18 | |
| 8-K | 2025-02-18 | 2025-02-15 | |
| 8-K | 2025-02-06 | — | |
| 8-K | 2025-01-21 | 2025-01-16 | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-10-24 | — | |
| 8-K | 2024-08-27 | — | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-06 | — | |
| 8-K | 2024-06-03 | 2024-06-02 | |
| 8-K | 2024-05-23 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| DEF 14A | 2024-04-23 | 2024-06-06 | |
| 8-K | 2024-02-21 | — | |
| 10-K | 2024-02-21 | 2023-12-31 | |
| 8-K | 2024-01-30 | 2024-01-29 | |
| 8-K | 2023-11-07 | — | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-08-07 | — |
Showing 1–50 of 111 filings
Key facts
CIK
1724521
CUSIP
03969F109
13F (30d)
199 filings
197 filers
Visit website
Investor relations